CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENT

CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENT

Aim. Increase of efficiency of pharmacological correction of hypertensive neuroretinopathy using a new dimethylaminoethanol (DMAE) derivative 7-16.Materials and methods. Modeling of hypertensive neuroretinopathy was carried out by introducing a nonselective inhibitor of NO-synthase N-nitro-L-arginin...

Full description

Bibliographic Details
Main Authors: A. A. PERESYPKINA, M. V. POKROVSKII, V. O. GUBAREVA, E. A. LEVKOVA
Format: Article
Language:Russian
Published: Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2018-02-01
Series:Кубанский научный медицинский вестник
Subjects:
dimethylaminoethanol
hypertensive neuroretinopathy
electroretinography
Online Access:https://ksma.elpub.ru/jour/article/view/1014

Internet

https://ksma.elpub.ru/jour/article/view/1014

Similar Items